annual CAPEX:
$16.95M-$1.56M(-8.42%)Summary
- As of today (May 21, 2025), ANIP annual capital expenditures is $16.95 million, with the most recent change of -$1.56 million (-8.42%) on December 31, 2024.
- During the last 3 years, ANIP annual CAPEX has fallen by -$6.68 million (-28.28%).
- ANIP annual CAPEX is now -88.63% below its all-time high of $149.06 million, reached on December 31, 2016.
Performance
ANIP CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$19.85M+$17.37M(+700.24%)Summary
- As of today (May 21, 2025), ANIP quarterly capital expenditures is $19.85 million, with the most recent change of +$17.37 million (+700.24%) on March 31, 2025.
- Over the past year, ANIP quarterly CAPEX has increased by +$15.27 million (+333.22%).
- ANIP quarterly CAPEX is now -76.80% below its all-time high of $85.55 million, reached on March 31, 2016.
Performance
ANIP quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$32.22M+$15.27M(+90.04%)Summary
- As of today (May 21, 2025), ANIP TTM capital expenditures is $32.22 million, with the most recent change of +$15.27 million (+90.04%) on March 31, 2025.
- Over the past year, ANIP TTM CAPEX has increased by +$11.48 million (+55.35%).
- ANIP TTM CAPEX is now -81.53% below its all-time high of $174.46 million, reached on June 30, 2016.
Performance
ANIP TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ANIP CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.4% | +333.2% | +55.4% |
| 3 y3 years | -28.3% | +811.2% | +28.5% |
| 5 y5 years | -38.5% | -65.5% | -50.3% |
ANIP CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.3% | +3.0% | at high | +1402.3% | at high | +624.0% |
| 5 y | 5-year | -75.2% | +3.0% | -65.5% | +5292.9% | -52.8% | +624.0% |
| alltime | all time | -88.6% | >+9999.0% | -76.8% | >+9999.0% | -81.5% | >+9999.0% |
ANIP CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $19.85M(+700.2%) | $32.22M(+90.0%) |
| Dec 2024 | $16.95M(-8.4%) | $2.48M(-54.4%) | $16.95M(-11.9%) |
| Sep 2024 | - | $5.44M(+22.3%) | $19.25M(+4.8%) |
| Jun 2024 | - | $4.45M(-2.9%) | $18.36M(-11.5%) |
| Mar 2024 | - | $4.58M(-4.1%) | $20.74M(+12.0%) |
| Dec 2023 | $18.51M(+12.5%) | $4.78M(+5.0%) | $18.51M(+9.7%) |
| Sep 2023 | - | $4.55M(-33.3%) | $16.87M(-23.8%) |
| Jun 2023 | - | $6.83M(+190.1%) | $22.14M(+33.1%) |
| Mar 2023 | - | $2.35M(-25.1%) | $16.63M(+1.1%) |
| Dec 2022 | $16.45M(-30.4%) | $3.14M(-68.0%) | $16.45M(+20.3%) |
| Sep 2022 | - | $9.81M(+642.9%) | $13.68M(+207.4%) |
| Jun 2022 | - | $1.32M(-39.3%) | $4.45M(-82.3%) |
| Mar 2022 | - | $2.18M(+491.8%) | $25.08M(+6.1%) |
| Dec 2021 | $23.64M(-65.4%) | $368.00K(-36.9%) | $23.64M(-6.9%) |
| Sep 2021 | - | $583.00K(-97.3%) | $25.39M(-17.1%) |
| Jun 2021 | - | $21.95M(+2878.3%) | $30.61M(+165.9%) |
| Mar 2021 | - | $737.00K(-65.2%) | $11.51M(-83.1%) |
| Dec 2020 | $68.32M(+148.0%) | $2.12M(-63.5%) | $68.32M(+1.1%) |
| Sep 2020 | - | $5.81M(+104.0%) | $67.58M(+6.1%) |
| Jun 2020 | - | $2.85M(-95.1%) | $63.70M(-1.7%) |
| Mar 2020 | - | $57.55M(+4088.2%) | $64.81M(+135.3%) |
| Dec 2019 | $27.55M(+152.5%) | $1.37M(-28.9%) | $27.55M(+1.4%) |
| Sep 2019 | - | $1.93M(-51.2%) | $27.18M(+2.1%) |
| Jun 2019 | - | $3.96M(-80.5%) | $26.62M(-7.9%) |
| Mar 2019 | - | $20.29M(+1914.4%) | $28.92M(+165.0%) |
| Dec 2018 | $10.91M(-89.9%) | $1.01M(-26.6%) | $10.91M(-81.8%) |
| Sep 2018 | - | $1.37M(-78.1%) | $60.02M(-1.8%) |
| Jun 2018 | - | $6.25M(+174.6%) | $61.13M(+6.9%) |
| Mar 2018 | - | $2.28M(-95.5%) | $57.18M(-47.1%) |
| Dec 2017 | $107.99M(-27.6%) | $50.12M(+1920.8%) | $107.99M(+82.2%) |
| Sep 2017 | - | $2.48M(+7.6%) | $59.27M(+2.4%) |
| Jun 2017 | - | $2.30M(-95.7%) | $57.88M(-50.4%) |
| Mar 2017 | - | $53.09M(+3722.5%) | $116.60M(-21.8%) |
| Dec 2016 | $149.06M(+356.1%) | $1.39M(+27.5%) | $149.06M(+0.2%) |
| Sep 2016 | - | $1.09M(-98.2%) | $148.78M(-14.7%) |
| Jun 2016 | - | $61.03M(-28.7%) | $174.46M(+53.5%) |
| Mar 2016 | - | $85.55M(+7642.2%) | $113.62M(+247.6%) |
| Dec 2015 | $32.68M(-8.6%) | $1.10M(-95.9%) | $32.68M(+2.4%) |
| Sep 2015 | - | $26.77M(>+9900.0%) | $31.92M(+15.3%) |
| Jun 2015 | - | $198.00K(-95.7%) | $27.68M(-0.2%) |
| Mar 2015 | - | $4.61M(+1264.5%) | $27.73M(-22.4%) |
| Dec 2014 | $35.75M(>+9900.0%) | $338.00K(-98.5%) | $35.75M(+0.9%) |
| Sep 2014 | - | $22.53M(+8804.3%) | $35.45M(+173.7%) |
| Jun 2014 | - | $253.00K(-98.0%) | $12.95M(+1.0%) |
| Mar 2014 | - | $12.63M(>+9900.0%) | $12.83M(+6615.2%) |
| Dec 2013 | $191.00K(-68.8%) | $29.00K(-14.7%) | $191.00K(-21.9%) |
| Sep 2013 | - | $34.00K(-73.4%) | $244.50K(-63.8%) |
| Jun 2013 | - | $128.00K(+55.2%) | $675.90K(+10.6%) |
| Dec 2012 | $611.20K | $82.50K(-82.3%) | $611.20K(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $465.40K(+5014.3%) | $603.00K(+150.9%) |
| Jun 2012 | - | $9100.00(-83.2%) | $240.30K(-56.5%) |
| Mar 2012 | - | $54.20K(-27.1%) | $552.90K(-23.2%) |
| Dec 2011 | $719.90K(+1035.5%) | $74.30K(-27.7%) | $719.90K(+5.9%) |
| Sep 2011 | - | $102.70K(-68.1%) | $680.10K(+16.8%) |
| Jun 2011 | - | $321.70K(+45.4%) | $582.50K(+110.4%) |
| Mar 2011 | - | $221.20K(+541.2%) | $276.80K(+336.6%) |
| Dec 2010 | $63.40K(-61.7%) | $34.50K(+576.5%) | $63.40K(+53.9%) |
| Sep 2010 | - | $5100.00(-68.1%) | $41.20K(+12.0%) |
| Jun 2010 | - | $16.00K(+105.1%) | $36.80K(+76.9%) |
| Mar 2010 | - | $7800.00(-36.6%) | $20.80K(-87.4%) |
| Dec 2009 | $165.70K(-74.6%) | $12.30K(+1657.1%) | $165.70K(-70.0%) |
| Sep 2009 | - | $700.00(>+9900.0%) | $551.70K(-18.3%) |
| Jun 2009 | - | $0.00(-100.0%) | $675.10K(-14.5%) |
| Mar 2009 | - | $152.70K(-61.7%) | $789.20K(+21.2%) |
| Dec 2008 | $651.10K(+2114.6%) | $398.30K(+221.0%) | $651.10K(+137.5%) |
| Sep 2008 | - | $124.10K(+8.8%) | $274.20K(+81.7%) |
| Jun 2008 | - | $114.10K(+681.5%) | $150.90K(+243.0%) |
| Mar 2008 | - | $14.60K(-31.8%) | $44.00K(+49.7%) |
| Dec 2007 | $29.40K(-25.2%) | $21.40K(+2575.0%) | $29.40K(+267.5%) |
| Sep 2007 | - | $800.00(-88.9%) | $8000.00(-81.2%) |
| Jun 2007 | - | $7200.00(>+9900.0%) | $42.50K(+8.4%) |
| Dec 2006 | $39.30K(-41.7%) | $0.00(-100.0%) | $39.20K(-35.4%) |
| Sep 2006 | - | $35.30K(+938.2%) | $60.70K(+119.9%) |
| Jun 2006 | - | $3400.00(+580.0%) | $27.60K(-31.2%) |
| Mar 2006 | - | $500.00(-97.7%) | $40.10K(-40.6%) |
| Dec 2005 | $67.40K(-34.7%) | $21.50K(+877.3%) | $67.50K(-12.5%) |
| Sep 2005 | - | $2200.00(-86.2%) | $77.10K(-9.0%) |
| Jun 2005 | - | $15.90K(-43.0%) | $84.70K(-15.9%) |
| Mar 2005 | - | $27.90K(-10.3%) | $100.70K(-2.3%) |
| Dec 2004 | $103.20K(+1059.6%) | $31.10K(+217.3%) | $103.10K(+35.1%) |
| Sep 2004 | - | $9800.00(-69.3%) | $76.30K(+7.3%) |
| Jun 2004 | - | $31.90K(+5.3%) | $71.10K(+81.4%) |
| Mar 2004 | - | $30.30K(+604.7%) | $39.20K(+340.4%) |
| Dec 2003 | $8900.00(-77.2%) | $4300.00(-6.5%) | $8900.00(+1.1%) |
| Sep 2003 | - | $4600.00(+9.5%) | $8800.00(-77.4%) |
| Dec 2002 | $39.00K(-55.0%) | $4200.00(-53.3%) | $39.00K(-13.7%) |
| Sep 2002 | - | $9000.00(-2.2%) | $45.20K(-49.8%) |
| Jun 2002 | - | $9200.00(-44.6%) | $90.00K(-11.1%) |
| Mar 2002 | - | $16.60K(+59.6%) | $101.20K(+16.7%) |
| Dec 2001 | $86.70K(+100.7%) | $10.40K(-80.7%) | $86.70K(-1.5%) |
| Sep 2001 | - | $53.80K(+163.7%) | $88.00K(+129.2%) |
| Jun 2001 | - | $20.40K(+871.4%) | $38.40K(+12.9%) |
| Mar 2001 | - | $2100.00(-82.1%) | $34.00K(-21.3%) |
| Dec 2000 | $43.20K(+928.6%) | $11.70K(+178.6%) | $43.20K(+37.1%) |
| Sep 2000 | - | $4200.00(-73.8%) | $31.50K(+15.4%) |
| Jun 2000 | - | $16.00K(+41.6%) | $27.30K(+141.6%) |
| Mar 2000 | - | $11.30K | $11.30K |
| Dec 1999 | $4200.00(-96.6%) | - | - |
| Dec 1998 | $125.00K | - | - |
FAQ
- What is ANI Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual CAPEX year-on-year change?
- What is ANI Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly CAPEX year-on-year change?
- What is ANI Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM CAPEX year-on-year change?
What is ANI Pharmaceuticals annual capital expenditures?
The current annual CAPEX of ANIP is $16.95M
What is the all time high annual CAPEX for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual capital expenditures is $149.06M
What is ANI Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, ANIP annual capital expenditures has changed by -$1.56M (-8.42%)
What is ANI Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of ANIP is $19.85M
What is the all time high quarterly CAPEX for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly capital expenditures is $85.55M
What is ANI Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, ANIP quarterly capital expenditures has changed by +$15.27M (+333.22%)
What is ANI Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of ANIP is $32.22M
What is the all time high TTM CAPEX for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM capital expenditures is $174.46M
What is ANI Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, ANIP TTM capital expenditures has changed by +$11.48M (+55.35%)